Endocrinology Advisor Contributing Writer

Researchers investigate whether asymptomatic atherosclerotic CVD can be prevented with an aggressive medical treatment that reduces LDL cholesterol to <60 mg/dl.

A team of investigators assessed the frequency with which patients with type 2 diabetes and heart failure were prescribed sodium-glucose co-transporter 2 inhibitors.

Researchers investigated the effects of RAAS antagonism on the severity of COVID-19 in patients with obesity-related hypertension.